Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:36 pm Purchase | 13G | ALLOGENE THERAPEUTICS INC ALLO | Belldegrun Arie | 9,895,903 5.8% | 1,037,042 (+11.71%) | View |
| 2023-02-13 4:31 pm Purchase | 13G | ALLOGENE THERAPEUTICS INC ALLO | Belldegrun Arie | 8,858,861 6.1% | 1,655,613 (+22.98%) | View |
| 2022-02-17 4:12 pm Purchase | 13G | KRONOS BIO INC KRON | Belldegrun Arie | 3,444,889 6.1% | 3,444,889 (New Position) | View |
| 2022-02-14 3:36 pm Purchase | 13G | ALLOGENE THERAPEUTICS INC ALLO | Belldegrun Arie | 7,203,248 5% | 708,755 (+10.91%) | View |
| 2021-02-12 2:32 pm Sale | 13G | ALLOGENE THERAPEUTICS INC ALLO | Belldegrun Arie | 6,494,493 4.6% | -859,507 (-11.69%) | View |
| 2020-02-13 4:07 pm Sale | 13G | ALLOGENE THERAPEUTICS INC ALLO | Belldegrun Arie | 7,354,000 6% | -4,560,389 (-38.28%) | View |